Development of Peptide Inhibitors of Cancer Cell Signaling Targets, STAT3 and LC3B

Cerulli, Robert


  • Despite decades of research and considerable advancements in the field of novel cancer therapeutics, there remains a high demand for new strategies and new molecules to combat aggressive, chemoresistant malignancies. Two cell signaling pathways that have been studied for several decades and have been the subject of inhibitor development, are STAT3 signaling and the autophagy pathway. There is ... read more
This object is in collection Creator department Thesis Type Genre Permanent URL
To Cite:
TARC Citation Guide    EndNote